Metabolomics Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Metabolomics Reagents was estimated to be worth US$ 26.18 million in 2023 and is forecast to a readjusted size of US$ 61.94 million by 2030 with a CAGR of 13.22% during the forecast period 2024-2030.
North American market for Metabolomics Reagents was valued at $ 10.10 million in 2023 and will reach $ 24.00 million by 2030, at a CAGR of 13.26% during the forecast period of 2024 through 2030.
Asia-Pacific market for Metabolomics Reagents was valued at $ 6.55 million in 2023 and will reach $ 16.22 million by 2030, at a CAGR of 13.97% during the forecast period of 2024 through 2030.
Europe market for Metabolomics Reagents was valued at $ 7.91 million in 2023 and will reach $ 18.18 million by 2030, at a CAGR of 12.77% during the forecast period of 2024 through 2030.
The global key companies of Metabolomics Reagents include Biocrates, Cambridge Isotope Laboratories, Metware Biotechnology, IROA Technologies and Beijing BGI-GBI Biotech Co., Ltd. (GBI) etc. In 2023, the global five largest players hold a share approximately 71.12% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Metabolomics Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Metabolomics Reagents by region & country, by Type, and by Application.
The Metabolomics Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolomics Reagents.
Market Segmentation
By Company
Biocrates
Cambridge Isotope Laboratories
Metware Biotechnology
IROA Technologies
Beijing BGI-GBI Biotech Co., Ltd. (GBI)
Fluidome
BIOTERE
Metabolomix
Segment by Type
Targeted Metabolomics
Untargeted Metabolomics
Segment by Application
Biological Companies
Research Institutions
Educational Institutions
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metabolomics Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Metabolomics Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Metabolomics Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.